International Journal of

Clinical CardiologyISSN: 2378-2951


 Open Access DOI:10.23937/2378-2951/1410160

Safety of Hydrochlorothiazide in the Real World: A Commentary on the Italian Medicines Agency (AIFA) Pronouncements

Valerio Massimo Magro, MD, Carla Coppola, MD, Eugenio Boccalone, MD, Michele Caturano, MD, Giovanni Scala, MD and Walter Verrusio, MD, PhD

Article Type: Commentaries | First Published: October 14, 2019

Thiazide diuretic drugs are the most commonly used molecules for the treatment of systemic hypertension. Despite their established role in the treatment of this disease, well recognized by the guidelines of national (such as the Italian Society of Cardiology - SIC - for example, which incorporates the directives of the European Society of Cardiology - ESC -) scientific societies. Several evidences have shown that hydrochlorothiazide therapy in chronic renal disease with advanced grade of kidney ...

 Open Access DOI:10.23937/2378-2951/1410159

Association between Platelet/Lymphocyte Ratio and Angiographic No-Reflow in Patients with None-St Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention

Ramazan Asoglu, Abdulmecit Afsin, Emin Asoglu3 and Arif Suner

Article Type: Research Article | First Published: September 26, 2019

Inflammation and platelet activation play a central role in the initiation and progression of the atherosclerosis process. The Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. The PLR is a significant independent predictor of longterm mortality after none-ST elevated myocardial infarction (NSTEMI). We aimed to evaluate the relationship between PLR and no-reflow (NR) in patients with NSTEMI. The present study included 173 patients with NSTEMI. The patients...

 Open Access DOI:10.23937/2378-2951/1410158

Systemic Atherosclerosis Treated by Hybrid Surgical and Systemic Percutaneous Endovascular Management

Walid Hassan, MD, MACP, FACC, FSCAI, Amr Aljareh, MD, Mariam Hassan, Khaldoun Al Saadi, MD and Sahar Sharaf Eldin, MD

Article Type: Case Report | First Published: September 23, 2019

Atherosclerotic disease in one arterial site, raise the probability of having other sites affected by about 50% within the vascular axis. Hence once vascular pathology found in one site i.e. coronary artery disease (CAD), other sites i.e. Cerebral and peripheral circulation must be assessed thoroughly, especially in patients with multiple risk factors. Percutaneous intervention (PCI) is a conservative reasonable solution for high risk and inoperable cases; sometimes it supersedes the choice surg...

 Open Access DOI:10.23937/2378-2951/1410157

A Modified Advanced Cardiac Life Support Algorithm

Abdulhalim Jamal Kinsara

Article Type: PATIENT CARE | First Published: September 21, 2019

Advanced cardiac life support (ACLS) has been made with many algorithms. We are suggesting a simple combined one as a time frame expected to attend is minutes and maintaining coherent neurological status is crucial. In institutions with multiple nationalities, the way in which ACLS is taught might vary and the time frame expected to attend the important minutes in saving a life and maintaining coherent neurological status might been delayed....

Volume 6
Issue 5